Ferric maltol clinical trials
Also written ST10 and ST10-01.
How each study uses ferric maltol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 25 Jul 2019 · ACCRUFER · NDA 212320 (FDA, Drugs@FDA)
- European Union
- 18 Feb 2016 · Feraccru · EMEA/H/C/002733 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 5
Shield Therapeutics (7) · Hannover Medical School (3) · Jiangsu Aosaikang Pharmaceutical Co., Ltd. (1) · The Royal Wolverhampton Hospitals NHS Trust (1) · Leiden University Medical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ferric maltol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 13
- Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel DiseaseCompletedPhase 3Jiangsu Aosaikang Pharmaceutical Co., Ltd.NCT07739368Written as Ferric Maltol
- Perioperative Iron for Colorectal Cancer (PICoC Study)CompletedPhase 3The Royal Wolverhampton Hospitals NHS TrustNCT05177484Written as oral ferric maltol
- Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 YearsCompletedPhase 3Shield TherapeuticsNCT05126901Written as Ferric Maltol
- Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy VolunteersCompletedPhase 1Shield TherapeuticsNCT04626414Written as Ferric maltol capsule
- ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)CompletedPhase 4Hannover Medical SchoolNCT05697211Written as Ferric maltol 30 mg (Feraccru®)
- Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel DiseaseStatus unknownPhase 4Leiden University Medical CenterNCT05456932Written as Ferric maltol
- Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron DeficiencyCompletedPhase 1Shield TherapeuticsNCT03181451Written as Ferric Maltol
- Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney DiseaseCompletedPhase 3Shield TherapeuticsNCT02968368Written as Ferric maltol
- Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBDCompletedPhase 3Shield TherapeuticsNCT02680756Written as Ferric Maltol
- Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)CompletedPhase 3Shield TherapeuticsNCT01340872Written as ST10-021
- Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)CompletedPhase 3Shield TherapeuticsNCT01352221Written as ST10
- ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)TerminatedPhase 3Hannover Medical SchoolNCT03371173Written as Ferric maltol 30 mg (Feraccru®)
- ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist DevicesTerminatedPhase 4Hannover Medical SchoolNCT03774615Written as Ferric maltol 30 mg (Feraccru®)
As the comparator · 2 — what is tested is compared with ferric maltol
- Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient WomenRecruitingPhase 4Pharmanutra S.p.a.NCT07308769Written as Ferric Maltol (Feraccru®)
- Evaluating the Effectiveness of Various Iron Salts in Oral Iron Therapy for Iron Deficiency and Anemia in Healthy AdultsActive, not recruitingNot applicableLiaquat University of Medical & Health SciencesNCT05985070Written as Oral Ferric maltol
Codes
What other systems call ferric maltol · ClinicalTrials.gg INT003478
- MeSH (NLM) C062088ferric maltolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) MA10QYF1Z0FERRIC MALTOLConfirmed FDA, NLM, Wikidata
- RxNorm 2539932One source FDA
- Wikidata Q27283748ferric maltolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174702Ferric MaltolOne source FDA
- DrugBank DB15598One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C062088 | ferric maltol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | MA10QYF1Z0 | FERRIC MALTOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2539932 | — | One source FDA |
| Wikidata | Q27283748 | ferric maltol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174702 | Ferric Maltol | One source FDA |
| DrugBank | DB15598 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.